Gujarat Themis Biosyn Limited
Status: Publicly traded
Direct answer
Gujarat Themis Biosyn Limited is publicly traded on BSE under the ticker GUJTHEM.BO.
Gujarat Themis Biosyn Limited functions as a pharmaceutical company, specializing in the production of various drugs. Its key pharmaceutical offerings include Rifamycin and Lovastatin. The company was incorporated on December 11, 1981, and maintains its headquarters in Mumbai, India.
Can you invest in Gujarat Themis Biosyn Limited?
Yes. Gujarat Themis Biosyn Limited is publicly traded on BSE under the ticker GUJTHEM.BO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Gujarat Themis Biosyn Limited
Detailed equity research is provided by MarketSnap.